Research & Development



  往年太學的學生在學習夠三年之後,就會進入朝堂觀政,為將來外出做官做準備,今年,則不然,更多的學子認為自己才學不夠,還需要學習……   阿哲很希望在未來五十年內能徹底發現,這東西的秘密。超碰无码视频caopoin   皇帝的目光從未離開過雲氏,這一點雲瑯是知道的,不過局面已經好的太多了。超碰在公开线视频免费   從地勢上來看,東宮城牆沒有未央城牆高大,也沒有未央宮厚,中間還有一道護城河,如果掘開護城河,所有的水就會流進東宮,算是佔盡了地理優勢。   雲瑯笑著對曹襄道︰“陛下還是冷靜的。”超碰97   雲瑯緩緩搖搖頭,冷笑著自言自語的道︰“你在史書上活了七十年,我很希望你這一次還能如此幸運。”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo